熱門資訊> 正文

RxSight任命新首席执行官

2026-07-16 04:18

RxSight(RXST) 0
Alcon(ALC) 0

RxSight (RXST) appointed Aziz Mottiwala as president and chief executive officer, effective July 20, 2026.
Mottiwala succeeds Ron Kurtz, M.D., who will remain with the company as chief medical officer.
Mottiwala most recently served as chief commercial officer at Tarsus Pharmaceuticals.

More on RxSight

RxSight: After Dropping To The Bottom, It's Time To Pick It Up
RxSight: Alcon Deal Reshapes The Long-Term Growth Story
RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript
RxSight anticipates $140M to $160M 2026 revenue as Alcon collaboration adds $30M to $40M
Alcon collaborates with RxSight to develop adjustable PCIOLs

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。